Recent News

• 03.31.2025 - Maze Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Highlights
• 03.31.2025 - Maze Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Highlights

Recent Filings

• 03.31.2025 - 8-K Current report
• 03.31.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.31.2025 - EX-99.1 EX-99.1
• 02.10.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.07.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.07.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.07.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.06.2025 - SEC STAFF LETTER SEC Staff Letter: REDACTED EXHIBIT
• 02.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2025 - 4 Statement of changes in beneficial ownership of securities